MetaCap

Axonex AI Group (AXNX) vs MOGU (MOGU)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

MOGU is the larger company by market cap ($14.1 million vs $5.3 million), about 2.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AXNX+16.92%MOGU-7.67%
+64%+10%-45%
Oct 13, 20261 yearNov 20, 2026
AXNX+76.17%MOGU-9.62%
+134%+57%-19%
Oct 12, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AXNX versus MOGU key metrics
MetricAXNXMOGU
Share price$0.8301$1.72
Market cap$5.28M$14.05M
1-day change-8.28%-8.66%
YTD return—-19.38%
1-year return—-33.18%
5-year return—-80.92%
Forward P/E—24.53
EPS (TTM)$-10.37$0.00
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$18.18M
Revenue growth (YoY)—-6.57%
Net income (latest FY)$-10.31M$266.00K
Gross margin—28.59%
Operating margin—-57.57%
Net margin—1.46%
52-week high$18.35$3.11
52-week low$0.68$1.27
Distance from 52-week high-95.48%-44.78%
Analyst consensushold—
Average volume2.01M9.59K
Shares outstanding6.08M7.17M
Employees797274
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • MOGU is about 2.7 times larger than Axonex AI Group by market value ($14.05M vs $5.28M).

About Axonex AI Group

AXNX stock →

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI.

Consumer Discretionary · Business Services · 797 employees

About MOGU

MOGU stock →

MOGU Inc., through its subsidiaries, operates an online fashion and lifestyle platform in the People's Republic of China. The company offers fashion apparel and other lifestyle products, including beauty products and accessories, as well as personal care, beauty makeup, food, medical beauty, healthcare, and grocery products; and household supplies.

Consumer Discretionary · Business Services · 274 employees

AXNX vs MOGU FAQ

Which is bigger, Axonex AI Group or MOGU?

MOGU (MOGU) is larger, with a market capitalization of $14.05M compared with $5.28M for Axonex AI Group (AXNX).

Are Axonex AI Group and MOGU in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons